Fathima, Nazish published the artcilePrescribing pattern of drugs in the treatment of hypertension in a tertiary care teaching hospital: a prospective observational study, COA of Formula: C18H19Cl2NO4, the main research area is hypertension antihypertension morbidity combination therapy.
Hypertension is a common chronic medical condition which is identified as the 3rd leading risk factor for global burden of diseases. According to Joint National Committee guidelines, hypertension is defined as elevated systolic blood pressure of =140mmHg or diastolic blood pressure of â?90mmHg. The objective of this study is to analyze the prescribing pattern associated with antihypertensives. A Prospective Observational study was carried out for a period of 6 mo in an inpatient department in Shamanur Shivashankarappa Institute of Medical Science and Research Center, a tertiary care teaching hospital, Davangere. The data was collected from case sheets of all inpatients taking at least one antihypertensive. A total of 150 prescriptions were analyzed, out of which, 88(58.66%) were males and 62(41.33%) were females. The mean age group of study population was found to be 60-80 years (52%). The most commonly reported co- morbidity along with hypertension was Diabetes mellitus 80 (53.33%). Monotherapy was most preferred therapy which was given in almost 76 (50.66%) followed by combination therapy. In monotherapy Calcium channel blockers 35(46.04%) was most commonly prescribed. The present study confirms that the Prescribing patterns of antihypertensive drugs were in concordance with joint national committee 8 guidelines for patients with different compelling indications. The most frequently prescribed class of drug as monotherapy was Calcium Channel Blockers, followed by diuretics, which was also the most commonly used class of drugs in combination therapy.
World Journal of Pharmaceutical Research published new progress about Antihypertensives. 72509-76-3 belongs to class pyridine-derivatives, name is 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C18H19Cl2NO4, COA of Formula: C18H19Cl2NO4.